Contra

Date 29 September 2014
Event ESMO 2014
Session Docetaxel is the standard of care for metastatic prostate cancer patients starting Androgen deprivation therapy (ADT)
Topics Cytotoxic agents
Prostate Cancer
Therapy
Biological therapy
Presenter Ian Tannock
Authors I.F. Tannock
  • Dept Of Medical Oncology, Princess Margaret Hospital, M5G 2M9 - Toronto/CA